@article{MTMT:34834666, title = {Az utazással kapcsolatos védőoltások • Travel-Related Vaccination}, url = {https://m2.mtmt.hu/api/publication/34834666}, author = {Péterfi, Zoltán}, doi = {10.1556/2065.185.2024.5.8}, journal-iso = {MAGYAR TUDOMÁNY}, journal = {MAGYAR TUDOMÁNY}, volume = {158}, unique-id = {34834666}, issn = {0025-0325}, year = {2024}, eissn = {1588-1245}, pages = {651-660}, orcid-numbers = {Péterfi, Zoltán/0000-0001-9658-153X} } @article{MTMT:34728591, title = {A mikrobiom és a kardiovaszkuláris egészség}, url = {https://m2.mtmt.hu/api/publication/34728591}, author = {Péterfi, Zoltán}, doi = {10.26430/CHUNGARICA.2024.54.1.32}, journal-iso = {CARDIOL HUNG}, journal = {CARDIOLOGIA HUNGARICA}, volume = {54}, unique-id = {34728591}, issn = {0133-5596}, abstract = {A bél mikrobiom fontos szerepet játszik számos betegség kialakulásában vagy annak progressziójában. Egy kevésbé ismert terület a kardiovaszkuláris rendszer betegségei és a mikrobiom közötti kapcsolat, a bél–szív tengely és ateroszklerózis kapcsolata. A bél mikrobiom hatását különböző közvetítő molekulákon, mint a lipopoliszacharid, trimetilamin, fenilactetil-glutamin, rövid szénláncú zsírsavak, másodlagos epesavak, keresztül fejti ki. A legtöbb hatás, nem közvetlen, hanem az anyagcsere-folyamatok megváltoztatásán keresztül érvényesül és tartós folyamat eredménye, ezért vizsgálata és az összefüggések bizonyítása is nehézségekbe ütközik. A bél mikrobiom egyensúlyának helyreállítása segíthet a kóros folyamatok megállításában vagy azok visszafordításában. Jelen közleményben összefoglaljuk az eddigi ismereteinket a mikrobiom anyagcseretermékeinek kardiovaszkuláris rendszerre való hatásáról, valamint a rendelkezésünkre álló lehetőségeket a kóros hatások kivédése érdekében.}, year = {2024}, eissn = {1588-0230}, pages = {32-38}, orcid-numbers = {Péterfi, Zoltán/0000-0001-9658-153X} } @article{MTMT:34398321, title = {The Role of the Intestinal Microbiome in Multiple Sclerosis—Lessons to Be Learned from Hippocrates}, url = {https://m2.mtmt.hu/api/publication/34398321}, author = {El-Sayed, Mohamed Mahmoud and Mohak, Sidhesh and Gala, Dhir and Fabian, Reka and Péterfi, Zoltán and Fabian, Zsolt}, doi = {10.3390/biology12121463}, journal-iso = {BIOLOGY-BASEL}, journal = {BIOLOGY-BASEL}, volume = {12}, unique-id = {34398321}, abstract = {Based on recent advances in research of chronic inflammatory conditions, there is a growing body of evidence that suggests a close correlation between the microbiota of the gastrointestinal tract and the physiologic activity of the immune system. This raises the idea that disturbances of the GI ecosystem contribute to the unfolding of chronic diseases including neurodegenerative pathologies. Here, we overview our current understanding on the putative interaction between the gut microbiota and the immune system from the aspect of multiple sclerosis, one of the autoimmune conditions accompanied by severe chronic neuroinflammation that affects millions of people worldwide.}, year = {2023}, eissn = {2079-7737}, orcid-numbers = {Mohak, Sidhesh/0009-0006-5917-4680; Gala, Dhir/0000-0003-1410-8576; Péterfi, Zoltán/0000-0001-9658-153X} } @article{MTMT:34306768, title = {Löffler endokarditisz talaján kialakult infektív endokarditisz esete}, url = {https://m2.mtmt.hu/api/publication/34306768}, author = {Rábai, Miklós and Sándor, Barbara and Magyar, Klára and Kenyeres, Péter and Várady, Edit and Tóth, Levente and Márton, Zsolt and Péterfi, Zoltán and Szabados, Eszter and Huszár, Judit and Tóth, Kálmán and Habon, Tamás and Halmosi, Róbert}, journal-iso = {CARDIOL HUNG}, journal = {CARDIOLOGIA HUNGARICA}, volume = {53}, unique-id = {34306768}, issn = {0133-5596}, year = {2023}, eissn = {1588-0230}, pages = {A339-A339}, orcid-numbers = {Péterfi, Zoltán/0000-0001-9658-153X} } @article{MTMT:34276104, title = {A Belügyminisztérium egészségügyi szakmai irányelve az epeút- és epehólyag-gyulladás diagnosztikus kritériumairól és terápiájáról. Klinikai egészségügyi szakmai irányelv}, url = {https://m2.mtmt.hu/api/publication/34276104}, author = {Czakó, László and Dubravcsik, Zsolt and Gyökeres, Tibor and Hritz, István and Illés, Dóra and Madácsy, László and Nagy, András and Péterfi, Zoltán and Szepes, Zoltán and Szücs, Ákos and Vincze, Áron}, journal-iso = {EGÉSZSÉGÜGYI KÖZLÖNY}, journal = {EGÉSZSÉGÜGYI KÖZLÖNY}, volume = {73}, unique-id = {34276104}, issn = {2063-1146}, year = {2023}, pages = {898-936}, orcid-numbers = {Péterfi, Zoltán/0000-0001-9658-153X} } @article{MTMT:34095174, title = {Migraine as a Disease Associated with Dysbiosis and Possible Therapy with Fecal Microbiota Transplantation}, url = {https://m2.mtmt.hu/api/publication/34095174}, author = {Kappéter, Ágnes and Sipos, Dávid and Varga, Adorján and Vigvári, Szabolcs József and Halda-Kiss, Bernadett and Péterfi, Zoltán}, doi = {10.3390/microorganisms11082083}, journal-iso = {MICROORGANISMS}, journal = {MICROORGANISMS}, volume = {11}, unique-id = {34095174}, issn = {2076-2607}, abstract = {Migraine is a painful neurological condition characterized by severe pain on one or both sides of the head. It may be linked to changes in the gut microbiota, which are influenced by antibiotic use and other factors. Dysbiosis, which develops and persists as a result of earlier antibiotic therapy, changes the composition of the intestinal flora, and can lead to the development of various diseases such as metabolic disorders, obesity, hematological malignancies, neurological or behavioral disorders, and migraine. Metabolites produced by the gut microbiome have been shown to influence the gut–brain axis. The use of probiotics as a dietary supplement may reduce the number and severity of migraine episodes. Dietary strategies can affect the course of migraines and are a valuable tool for improving migraine management. With fecal microbiota transplantation, gut microbial restoration is more effective and more durable. Changes after fecal microbiota transplantation were studied in detail, and many data help us to interpret the successful interventions. The microbiological alteration of the gut microflora can lead to normalization of the inflammatory mediators, the serotonin pathway, and influence the frequency and intensity of migraine pain.}, year = {2023}, eissn = {2076-2607}, orcid-numbers = {Péterfi, Zoltán/0000-0001-9658-153X} } @article{MTMT:34025825, title = {A széklettranszplantáció aktuális hazai helyzete}, url = {https://m2.mtmt.hu/api/publication/34025825}, author = {Péterfi, Zoltán and Varga, Adorján and Vigvári, Szabolcs József and Sipos, Dávid}, doi = {10.33570/CEUJGH.9.2.59}, journal-iso = {CENT EUR J GASTRO HEPATOL}, journal = {CENTRAL EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY / GASZTROENTEROLÓGIAI ÉS HEPATOLÓGIAI SZEMLE}, volume = {9}, unique-id = {34025825}, year = {2023}, eissn = {2415-9107}, pages = {59-62}, orcid-numbers = {Péterfi, Zoltán/0000-0001-9658-153X} } @article{MTMT:33842885, title = {Epeút- és epehólyag-gyulladás: diagnosztikus kritériumok és terápia [Cholangitis and cholecystitis: diagnostic criteria and management]}, url = {https://m2.mtmt.hu/api/publication/33842885}, author = {Czakó, László and Gyökeres, Tibor Zoltán and Hritz, István and Madácsy, László and Illés, Dóra and Szepes, Zoltán and Dubravcsik, Zsolt and Péterfi, Zoltán and Nagy, András and Szűcs, Ákos and Vincze, Áron}, doi = {10.1556/650.2023.32770}, journal-iso = {ORV HETIL}, journal = {ORVOSI HETILAP}, volume = {164}, unique-id = {33842885}, issn = {0030-6002}, abstract = {In developed countries, diseases of the gallbladder and the biliary tract count as some of the most frequent gastrointestinal disorders. The inflammation of the gallbladder/biliary tree is a potentially severe, even lethal condition that requires rapid diagnosis and early multidisciplinary approach to be treated. Although the frequency of these diseases is high, the treatment is not unified in Hungary yet. The aim of the evidence-based recommendation is to clarify the diagnostic criteria and severity grading of these diseases and to highlight the indications and rules of proper application of the numerous available therapeutic interventions. The recent guideline is based on the consensus of the Board members of the Endoscopic Section of the Hungarian Gastroenterology Society in contribution with renown experts of surgery, infectology as well as interventional radiology and it counts as a clear and easy applicable guide during the all-day healthcare practice. Our guidelines are based on Tokyo guidelines established on the basis of the consensus reached in the International Consensus Meeting held in Tokyo which were revised in 2013 (TG13) and in 2018 (TG18). Orv Hetil. 2023; 164(20): 770-787.}, keywords = {Cholecystectomy; antimicrobial therapy; Acute cholecystitis; CHOLECYSTECTOMIA; antibiotikus kezelés; biliary drainage; Severity grading; acute cholangitis; akut cholangitis; akut cholecystitis; epeúti drenázs; súlyossági osztályozás}, year = {2023}, eissn = {1788-6120}, pages = {770-787}, orcid-numbers = {Czakó, László/0000-0002-6331-0802; Hritz, István/0000-0002-8763-6006; Szepes, Zoltán/0000-0002-9466-8719; Péterfi, Zoltán/0000-0001-9658-153X; Vincze, Áron/0000-0003-2217-7686} } @article{MTMT:33588242, title = {Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Clostridioides difficile Infection – A novel method for capsule faecal microbiota transfer}, url = {https://m2.mtmt.hu/api/publication/33588242}, author = {Varga, Adorján and Makszin, Lilla and Bufa, Anita and Sipos, Dávid and Kása, Péter and Pál, Szilárd and Rosenstiel, Philip and Sommer, Felix and Kocsis, Béla and Péterfi, Zoltán}, doi = {10.3389/fcimb.2023.1041384}, journal-iso = {FRONT CELL INFECT MI}, journal = {FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY}, volume = {13}, unique-id = {33588242}, issn = {2235-2988}, year = {2023}, eissn = {2235-2988}, orcid-numbers = {Makszin, Lilla/0000-0002-9764-4763; Kása, Péter/0000-0002-6134-0928; Péterfi, Zoltán/0000-0001-9658-153X} } @article{MTMT:33567482, title = {Adverse Reactions after Booster SARS-CoV-2 Vaccination Have Less Impact on Antibody Response than after Basic Vaccination Scheme}, url = {https://m2.mtmt.hu/api/publication/33567482}, author = {Kanizsai, Andrea and Zavori, Laszlo and Molnár, Tihamér and Tőkés-Füzesi, Margit and Szalai, Zoltan and Berecz, Janos and Várnai, Réka and Péterfi, Zoltán and Schwarcz, Attila and Csécsei, Péter}, doi = {10.3390/vaccines11010182}, journal-iso = {VACCINES-BASEL}, journal = {VACCINES (BASEL)}, volume = {11}, unique-id = {33567482}, abstract = {Background: It is known that adverse reactions following SARS-CoV-2 vaccinations show a positive correlation with the subsequent antibody titer. However, it is not clear how the adverse reactions following the booster vaccination are related to the antibody levels that can be measured after a 3rd dose. The primary goal of this study was to investigate whether the adverse reactions following the booster vaccination show a correlation with subsequent antibody levels. Methods: Adverse reactions occurring within 7 days after the 3rd vaccination were recorded and the anti-SARS-CoV-2 spike protein immunoglobulin (Ig) level in the venous blood was measured on post-vaccination 14th, 60th and 120th days. Results: A total of 218 volunteers were included in the study. Main findings: (i) The adverse reactions that appeared after the booster dose did not show a positive correlation with the subsequent antibody level, except a correlation in the case of fever; (ii) there were more symptomatic patients in the group receiving heterologous booster vaccine, (iii) fever after the 2nd dose was independently associated with a reduction in the likelihood of COVID-19 positivity after the booster dose. Conclusion: No adverse reactions, but fever showed a correlation with the antibody level after the booster SARS-CoV-2 vaccine.}, year = {2023}, eissn = {2076-393X}, orcid-numbers = {Zavori, Laszlo/0000-0002-1715-4167; Péterfi, Zoltán/0000-0001-9658-153X} }